Profile data is unavailable for this security.
About the company
Kindstar Globalgene Technology Inc is a China-based investment holding company principally engaged in the provision of clinical testing services. The Company operates nine segments. Hematology Testing segment includes testing services related to blood diseases. Genetic Diseases and Rare Diseases segment includes testing services from the rare disease. Infectious Diseases segment includes testing services from the infection department. Oncology segment includes testing related to oncology diseases. Neurology segment includes testing services related to neurological diseases undertaken by the Group. Maternity-related Diseases segment includes testing services related to maternity. COVID-19 Related Testing segment includes testing services related to COVID-19. Routine Testing segment conducts routine tests for the doctors’ daily diagnoses. The Others segment includes testing services for research and development (R&D) projects and others and miscellaneous services.
- Revenue in HKD (TTM)1.05bn
- Net income in HKD44.63m
- Incorporated2007
- Employees3.13k
- LocationKindstar Globalgene Technology IncEast Lake High Tech ZoneBiolake D2-1, 666 Gaoxin RoadWUHAN ChinaCHN
- Websitehttps://www.kindstar.com.cn/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Guangdong Kanghua Healthcare Co Ltd | 2.21bn | 130.86m | 785.83m | 3.95k | 6.01 | 0.5105 | 3.11 | 0.356 | 0.3913 | 0.3913 | 6.60 | 4.60 | 0.7641 | 17.98 | 8.48 | 559,343.80 | 3.41 | 1.42 | 4.98 | 2.05 | 17.85 | 17.09 | 4.46 | 1.92 | 1.32 | -- | 0.2217 | 0.00 | 10.63 | 4.49 | 102.79 | -6.34 | 7.70 | -- |
| Wenzhou Kangning Hospital Co Ltd | 1.73bn | 92.91m | 902.66m | 4.77k | 9.72 | 0.6601 | 4.20 | 0.5231 | 1.25 | 1.25 | 23.13 | 18.33 | 0.5615 | 20.04 | 3.97 | 362,120.10 | 3.06 | 1.69 | 4.39 | 2.43 | 25.35 | 24.56 | 5.45 | 3.19 | 1.16 | 3.50 | 0.4429 | 13.64 | 7.50 | 16.43 | 454.85 | 1.39 | 4.32 | 20.91 |
| Honliv Healthcare Management Grp Co Ltd | 822.10m | 41.41m | 1.51bn | 1.97k | 35.28 | 2.58 | 14.16 | 1.84 | 0.0714 | 0.0714 | 1.41 | 0.9762 | 0.799 | 20.07 | 19.25 | 417,521.90 | 4.07 | 4.50 | 6.91 | 8.73 | 19.05 | 23.05 | 5.09 | 6.26 | 0.7684 | 12.08 | 0.2482 | 0.00 | 4.50 | 8.90 | -21.73 | -12.03 | 66.84 | -- |
| Kindstar Globalgene Technology Inc | 1.05bn | 44.63m | 1.55bn | 3.13k | 34.09 | 0.4664 | 12.86 | 1.48 | 0.0461 | 0.0461 | 1.08 | 3.37 | 0.2616 | 9.61 | 1.61 | 334,582.80 | 0.9858 | -21.99 | 1.27 | -35.48 | 46.64 | 48.76 | 3.77 | -49.51 | 3.58 | 6.69 | 0.0629 | -- | -30.24 | 6.49 | -45.29 | -- | 23.67 | -- |
| MedSci Healthcare Holdings Ltd | 377.47m | 59.50m | 1.60bn | 545.00 | 23.44 | 1.16 | 23.30 | 4.23 | 0.1122 | 0.1122 | 0.7278 | 2.26 | -- | -- | -- | 692,597.10 | -- | -- | -- | -- | 62.03 | -- | 15.76 | -- | -- | 268.03 | 0.0041 | -- | 0.0699 | -- | 155.11 | -- | -- | -- |
| EuroEyes International Eye Clinic Ltd | 714.29m | 131.24m | 1.70bn | 290.00 | 12.91 | 1.50 | 7.70 | 2.38 | 0.395 | 0.395 | 2.15 | 3.41 | 0.4336 | 23.28 | 114.79 | 2,463,066.00 | 8.09 | 6.18 | 9.19 | 7.20 | 46.97 | 45.81 | 18.66 | 14.31 | 4.53 | -- | 0.248 | -- | 17.04 | 12.44 | 46.69 | 29.91 | 34.24 | -- |
| EC Healthcare | 4.10bn | -3.74m | 1.80bn | 2.72k | -- | 0.9583 | 2.87 | 0.439 | -0.0032 | -0.0032 | 3.47 | 1.59 | 0.7615 | 6.23 | 16.48 | 1,591,122.00 | 0.4315 | 7.50 | 0.6815 | 13.41 | 84.71 | 87.53 | 0.5666 | 10.24 | 0.8144 | 1.08 | 0.3893 | 93.06 | 32.74 | 24.27 | -64.73 | -24.25 | 51.52 | 14.87 |
| Town Health International Medical Gp Ltd | 1.83bn | -194.21m | 1.93bn | 1.40k | -- | 0.5954 | -- | 1.05 | -0.0287 | -0.0287 | 0.2706 | 0.4787 | 0.3963 | 24.25 | 5.04 | 1,310,249.00 | -3.44 | -1.21 | -4.29 | -1.44 | 27.38 | 29.06 | -8.68 | -4.01 | 3.16 | 1.34 | 0.1121 | -- | 19.37 | 10.32 | -1,370.26 | -- | -25.95 | -13.65 |
| Rici Healthcare Holdings Ltd | 3.23bn | 393.26m | 1.96bn | 9.41k | 4.97 | 1.61 | 2.89 | 0.6047 | 0.2473 | 0.2473 | 2.03 | 0.766 | 0.6503 | 45.80 | 10.35 | 343,671.80 | 8.73 | 3.24 | 16.25 | 5.78 | 41.75 | 37.00 | 13.43 | 5.93 | 0.6471 | 5.64 | 0.6705 | 0.00 | 26.01 | 16.85 | 56.06 | -- | 2.51 | -- |
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Advisors LLCas of 30 Apr 2024 | 21.17m | 2.14% |
| Fidelity Management & Research (Hong Kong) Ltd.as of 31 Mar 2024 | 8.90m | 0.90% |
| Carmignac Gestion SAas of 28 Mar 2024 | 7.69m | 0.78% |
| BlackRock Investment Management LLCas of 31 Mar 2024 | 7.15m | 0.72% |
| Fidelity Management & Research Co. LLCas of 29 Feb 2024 | 2.11m | 0.21% |
| Amundi (UK) Ltd.as of 28 Mar 2024 | 2.03m | 0.21% |
| UBS Asset Management (Hong Kong) Ltd.as of 30 Jun 2022 | 1.18m | 0.12% |
| DNCA Finance SAas of 30 Jun 2023 | 828.19k | 0.08% |
